Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (71-80 of 474) with videos related to

Pageof 48
Sort By:
World Journal of Urology|February 9, 2019
Re: Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective studyJoseph M Norris, Mark Emberton, Clement Orczyk
Urology|August 30, 2014
Re: Jarow et al.: Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop (Urology 2014;83:975-979)Massimo Valerio, Mark Emberton, Hashim U Ahmed
European Urology|July 5, 2021
An update from the ReIMAGINE Prostate Cancer Risk Study (NCT04060589): A prospective cohort study in men with a suspicion of prostate cancer who are referred onto a magnetic resonance imaging-based diagnostic pathway with donation of tissue, blood, and urine for biomarker analysesTeresa Marsden, Hashim U Ahmed, Mark Emberton, et al.
European Urology|June 26, 2018
"Don't Let the Perfect Be the Enemy of the Good": Time to Embrace Magnetic Resonance Imaging Before First Prostate BiopsyVeeru Kasivisvanathan, Mark Emberton, Caroline M Moore
Nature Clinical Practice. Urology|January 10, 2009
Photodynamic therapy for prostate cancer--a review of current status and future promiseCaroline M Moore, Doug Pendse, Mark Emberton
Current Opinion in Urology|March 28, 2014
Biopsy strategies for selecting patients for focal therapy for prostate cancerAbi Kanthabalan, Mark Emberton, Hashim U Ahmed
BJU International|September 8, 2006
A systematic review of the reliability of frequency-volume charts in urological research and its implications for the optimum chart durationTet L Yap, David C Cromwell, Mark Emberton
BJU International|November 17, 2005
When thinking of initiating medical therapy for lower urinary tract symptoms, ask about cataractsPaul Cathcart, Rathie Rajendram, Ranjan Rajendram, et al.
Lasers in Surgery and Medicine|November 8, 2011
Photodynamic therapy for prostate cancer--an emerging approach for organ-confined diseaseCaroline M Moore, Mark Emberton, Stephen G Bown
BJU International|September 13, 2005
Lower urinary tract symptoms in men: self-perceptions and the concept of botherKenneth Gannon, Lesley Glover, Marie O'Neill, et al.
Pageof 48

Showing results (71-80 of 474) with videos related to

Sort By:
Pageof 48
World Journal of Urology|February 9, 2019
Re: Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective studyJoseph M Norris, Mark Emberton, Clement Orczyk
Urology|August 30, 2014
Re: Jarow et al.: Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop (Urology 2014;83:975-979)Massimo Valerio, Mark Emberton, Hashim U Ahmed
European Urology|July 5, 2021
An update from the ReIMAGINE Prostate Cancer Risk Study (NCT04060589): A prospective cohort study in men with a suspicion of prostate cancer who are referred onto a magnetic resonance imaging-based diagnostic pathway with donation of tissue, blood, and urine for biomarker analysesTeresa Marsden, Hashim U Ahmed, Mark Emberton, et al.
European Urology|June 26, 2018
"Don't Let the Perfect Be the Enemy of the Good": Time to Embrace Magnetic Resonance Imaging Before First Prostate BiopsyVeeru Kasivisvanathan, Mark Emberton, Caroline M Moore
Nature Clinical Practice. Urology|January 10, 2009
Photodynamic therapy for prostate cancer--a review of current status and future promiseCaroline M Moore, Doug Pendse, Mark Emberton
Current Opinion in Urology|March 28, 2014
Biopsy strategies for selecting patients for focal therapy for prostate cancerAbi Kanthabalan, Mark Emberton, Hashim U Ahmed
BJU International|September 8, 2006
A systematic review of the reliability of frequency-volume charts in urological research and its implications for the optimum chart durationTet L Yap, David C Cromwell, Mark Emberton
BJU International|November 17, 2005
When thinking of initiating medical therapy for lower urinary tract symptoms, ask about cataractsPaul Cathcart, Rathie Rajendram, Ranjan Rajendram, et al.
Lasers in Surgery and Medicine|November 8, 2011
Photodynamic therapy for prostate cancer--an emerging approach for organ-confined diseaseCaroline M Moore, Mark Emberton, Stephen G Bown
BJU International|September 13, 2005
Lower urinary tract symptoms in men: self-perceptions and the concept of botherKenneth Gannon, Lesley Glover, Marie O'Neill, et al.
Pageof 48